Abstract Descemet Membrane Endothelial Keratoplasty (DMEK) has become a first-line treatment in corneal endothelial diseases owing to its exceptional clinical outcomes and low complication rates. Thanks refractive predictability the ability reshape superficial cornea, DMEK is now also considered for managing cases with decompensation following previous procedures. This article reviews of three ...